LA-CAB/RPVLong-acting injectable antiretroviral therapycabotegravir/rilpivirine
…g hours were considered adequate for 85%.Treatment Convenience: LA-CAB/RPV was perceived as more convenient than daily oral ART by 95% of …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 121–180 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Medications11Pharmacological treatment11Radiation therapy11conservative treatment11Hormone replacement therapy11Intravenous antibiotics11DBS10Flow diversion10NIV10Kidney transplantation10Spinal anaesthesia10General anesthesia10Antibiotic treatment10Cancer immunotherapies10antimicrobial therapy10Middle meningeal artery (MMA) embolization10TPT9PR9Cataract surgery9CBT9Biologics9Chemoimmunotherapy9Reperfusion therapy9Angioplasty9CAR T cell therapy9usual care9Revascularisation9Transplantation9Intra-arterial chemotherapy9Analgesia9Cardiac resynchronisation therapy9treatments9Antihypertensive Treatment8PCI8assisted dying8Neuraxial anesthesia8Aspiration thrombectomy8immunosuppressants8CAR T-cell therapy8therapies8Anti-TNF therapy8Carotid artery stenting8Transcatheter Aortic Valve Implantation8medical management8radiation8Therapeutic hypothermia8active treatment8antiretroviral treatment8blood transfusions8immunomodulatory therapy8SAPT7Probiotics7Thermal Ablation7RT7Coiling7CRT7Parenteral nutrition7Maintenance therapy7Electroacupuncture7Exercise therapy7
Articles mentioning treatments
7,227 articles · page 26 of 603EUS-CGLAMSJoanna Briggs InstitutePFCs
…5% to 100%, respectively, with pooled recurrence ≈6%.Conclusion EUS-CG is a safe, feasible and highly effective treatment for PFCs in …
Parathyroidectomynon-surgical managementPrimary hyperparathyroidismPHPTCochrane Central Register of Controlled Trialsrenal stonesEMBASECKD
…ses the risk of renal stones and progressive renal dysfunction. Parathyroidectomy is recommended for patients with renal involvement, yet whether…
CPAPNIVBiPAPneurodisabilityPediatr. Pulmonol. 2021remote monitoring
…ely using a telemonitoring-compatible device. Of these, 13 used CPAP and 7 were on BiPAP. Median NIV usage was 76/90 days, and media…
PRTiodine-125 plaque radiotherapyBeijing Tongren Hospitaluveal melanoma
…egrouped the patients who underwent secondary enucleation after PRT. These differences in histopathology may represent tissue effec…
chemotherapychemoimmunotherapypaclitaxelcamrelizumabcisplatinChiCTR2000040034ESCC
…d with chemotherapy has demonstrated higher response rates than chemotherapy alone in resectable esophageal squamous cell carcinoma (ESCC). …
CBTTAUcognitive–behavioural therapyChronic non-cancer pain
…ical magnitude of this effect? And, in a nutshell, should I use CBT instead of TAU to tackle pain in adults with chronic pain?…
Effect of deep brain stimulation on patients with Parkinson’s disease with mild cognitive impairment
Deep brain stimulationDBSParkinson’s diseasePD-MCIPDDPDEmbasePubMed
…rkinson’s disease (PD), often progressing to PD dementia (PDD). Deep brain stimulation (DBS) is an established treatment for PD motor symptoms, but it…
IPPdiabeteshypercholesterolaemiahypertensionchronic non-communicable diseases (cNCDs)IPP
…e evaluated the evidence of independent pharmacist prescribing (IPP) in the treatment of metabolic targets associated with chronic …
PrEPPre-exposure prophylaxisPrEP-relatedtenofovir disoproxilemtricitabineHIVNational Health ServiceNHSItalian Medicines Agency
…analysis, of whom three women and 124 men. Among them, 76% used PrEP on-demand, and 22% on a daily regime. At the time of the most r…
PrEPdiabetesgonorrhoeasyphilisdyslipidaemiaHIVhypertensionchlamydianephropathyliver disease
…d diabetes (4.26%). 12% percent had nephropathy before starting PrEP. Serum creatinine (0.95 ± 0.46 g/dL) and phosphorus (3.43 ± 1.7…